Dual ontogeny of disease-associated microglia and disease inflammatory macrophages in aging and neurodegeneration.

Alzheimer’s disease aging disease inflammatory macrophages disease-associated microglia macrophage microglia neurodegeneration

Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
09 08 2022
Historique:
received: 18 02 2022
revised: 18 04 2022
accepted: 07 07 2022
pubmed: 6 8 2022
medline: 13 8 2022
entrez: 5 8 2022
Statut: ppublish

Résumé

Brain macrophage populations include parenchymal microglia, border-associated macrophages, and recruited monocyte-derived cells; together, they control brain development and homeostasis but are also implicated in aging pathogenesis and neurodegeneration. The phenotypes, localization, and functions of each population in different contexts have yet to be resolved. We generated a murine brain myeloid scRNA-seq integration to systematically delineate brain macrophage populations. We show that the previously identified disease-associated microglia (DAM) population detected in murine Alzheimer's disease models actually comprises two ontogenetically and functionally distinct cell lineages: embryonically derived triggering receptor expressed on myeloid cells 2 (TREM2)-dependent DAM expressing a neuroprotective signature and monocyte-derived TREM2-expressing disease inflammatory macrophages (DIMs) accumulating in the brain during aging. These two distinct populations appear to also be conserved in the human brain. Herein, we generate an ontogeny-resolved model of brain myeloid cell heterogeneity in development, homeostasis, and disease and identify cellular targets for the treatment of neurodegeneration.

Identifiants

pubmed: 35931085
pii: S1074-7613(22)00337-5
doi: 10.1016/j.immuni.2022.07.004
pii:
doi:

Substances chimiques

Membrane Glycoproteins 0
Receptors, Immunologic 0
Trem2 protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1448-1465.e6

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests A.S. and F.G. are inventors on a patent filed, owned, and managed by A∗ccelerate technologies Pte Ltd, A(∗)STAR, Singapore, on technology related to the work presented in this manuscript.

Auteurs

Aymeric Silvin (A)

Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif 94800, France.

Stefan Uderhardt (S)

Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, 91054 Erlangen, Germany; Deutsches Zentrum für Immuntherapie, FAU, 91054 Erlangen, Germany; Exploratory Research Unit, Optical Imaging Centre Erlangen, FAU, 91058 Erlangen, Germany.

Cecile Piot (C)

Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.

Sandro Da Mesquita (S)

Department of Neuroscience, Center for Brain Immunology and Glia, University of Virginia, Charlottesville, VA 22908, USA; Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.

Katharine Yang (K)

Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.

Laufey Geirsdottir (L)

Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.

Kevin Mulder (K)

INSERM U1015, Gustave Roussy Cancer Campus, Villejuif 94800, France.

David Eyal (D)

Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.

Zhaoyuan Liu (Z)

Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Cecile Bridlance (C)

Institut de Biologie de l'Ecole Normale Supérieure (IBENS), Ecole Normale Supérieure, CNRS, INSERM, PSL Research University, 75005 Paris, France.

Morgane Sonia Thion (MS)

Institut de Biologie de l'Ecole Normale Supérieure (IBENS), Ecole Normale Supérieure, CNRS, INSERM, PSL Research University, 75005 Paris, France.

Xiao Meng Zhang (XM)

Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.

Wan Ting Kong (WT)

Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.

Marc Deloger (M)

INSERM US23, CNRS UMS 3655, Gustave Roussy Cancer Campus, Villejuif 94800, France.

Vasco Fontes (V)

Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, 91054 Erlangen, Germany; Deutsches Zentrum für Immuntherapie, FAU, 91054 Erlangen, Germany; Exploratory Research Unit, Optical Imaging Centre Erlangen, FAU, 91058 Erlangen, Germany.

Assaf Weiner (A)

Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.

Rachel Ee (R)

Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.

Regine Dress (R)

Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.

Jing Wen Hang (JW)

Department of Microbiology and Immunology, Immunology Translational Research Programme, Yong Loo Lin School of Medicine, Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore 117543, Singapore.

Akhila Balachander (A)

Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.

Svetoslav Chakarov (S)

Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore; Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Benoit Malleret (B)

Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore; Department of Microbiology and Immunology, Immunology Translational Research Programme, Yong Loo Lin School of Medicine, Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore 117543, Singapore.

Garett Dunsmore (G)

INSERM U1015, Gustave Roussy Cancer Campus, Villejuif 94800, France.

Olivier Cexus (O)

INSERM U1015, Gustave Roussy Cancer Campus, Villejuif 94800, France; School Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK.

Jinmiao Chen (J)

Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.

Sonia Garel (S)

Institut de Biologie de l'Ecole Normale Supérieure (IBENS), Ecole Normale Supérieure, CNRS, INSERM, PSL Research University, 75005 Paris, France.

Charles Antoine Dutertre (CA)

Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif 94800, France.

Ido Amit (I)

Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.

Jonathan Kipnis (J)

Department of Neuroscience, Center for Brain Immunology and Glia, University of Virginia, Charlottesville, VA 22908, USA; Center for Brain Immunology and Glia, Department of Pathology and Immunology, School of Medicine, Washington University in St Louis, St Louis, MO 63110, USA.

Florent Ginhoux (F)

Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif 94800, France; Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; Translational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore 169856, Singapore. Electronic address: florent_ginhoux@immunol.a-star.edu.sg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH